Developer docs
API playgroundTry for free, no card

Search company profiles

Cambrooke Therapeutics

Full company profile

uuid000afcl

Namestring
Cambrooke Therapeutics
Legal namestring
Ajinomoto Cambrooke, Inc.
Websiteurl
cambrooke.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Cambrooke Therapeutics (legally Ajinomoto Cambrooke, Inc.) is a US-based specialty medical nutrition company founded in 2000 by Lynn and David Paolella in Natick, Massachusetts, now headquartered in Ayer, MA. The company develops, manufactures, and commercializes medical foods and nutritional therapies for patients with inborn errors of metabolism — primarily phenylketonuria (PKU), tyrosinemia (TYR), homocystinuria (HCU), maple syrup urine disease (MSUD), isovaleric acidemia (IVA), and intractable epilepsy — as well as low-protein specialty foods for related dietary conditions.

The company's core technological differentiator is its proprietary glycomacropeptide (GMP)-based platform, commercialized under the Glytactin brand for PKU and Tylactin for tyrosinemia. GMP is a naturally occurring low-phenylalanine whole protein derived from whey through a cheese-making process, combined with large neutral amino acids (LNAAs). The company claims this formulation stabilizes phenylalanine levels throughout the day, reduces Phe absorption across the blood-brain barrier, and normalizes ghrelin (hunger hormone) levels. The broader product portfolio includes amino acid formulas (Homactin AA Plus, Vilactin AA Plus, Isovactin AA Plus), the KetoVie ketogenic formula line for intractable epilepsy, KetoVie Café ready-to-eat ketogenic foods, an extensive low-protein specialty food catalog, and ENU Nutrition shakes. In December 2025, the company launched DreamCap, a new user-friendly closure system compatible with the BoLink feeding platform.

The business operates a direct-to-consumer e-commerce model (shop.cambrooke.com and a separate Canadian storefront) supplemented by a healthcare professional channel with Salesforce-powered sample requests, clinical training, and reimbursement support. Medical formulas are reimbursed via HCPCS codes B4157 and B4162. Products are sold on a one-time purchase basis with unit and case pricing tiers (e.g., KetoVie Café Cinnamon Donut Delights at $15.99 single / $79.69 case). Since 2017, Cambrooke has operated as a wholly-owned subsidiary of Japanese food and biotechnology conglomerate Ajinomoto Co., Inc., which has supported international expansion into the UK, Germany, Canada, and Australia.

Short descriptiontext

Cambrooke Therapeutics, a wholly-owned Ajinomoto subsidiary, develops and sells GMP-based medical foods (Glytactin, Tylactin, KetoVie) and low-protein specialty foods for patients with rare inborn errors of metabolism including PKU, tyrosinemia, MSUD, HCU, and intractable epilepsy, primarily through direct-to-consumer e-commerce and healthcare provider channels across the US, Canada, UK, Germany, and Australia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAyer, United States
HQ citystring
Ayer
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical nutrition products, therapeutic medical foods, metabolic disorder formulas, low protein specialty foods, ketogenic medical formulas
Industry4 codes
PRIMARYCRADAGAN
Medical Nutrition & Meal Replacement (RTD, Bars, Powders)
SECONDARYAFAKAJAD
Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium)
Agriculture & Food Production/Food Processing & Manufacturing/Specialty & Functional Foods Manufacturing (Organic, Fortified, Medical Foods)
SECONDARYCRADAEAB
Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic)
SECONDARYCRADABAM
Better-for-You / Functional Snacks (Low Sugar, Keto, Probiotic, Fortified)
NAICS code2 codes
  • Food Manufacturing311
  • Food (Health) Supplement Retailers456191
SIC code2 codes
  • Miscellaneous Food Preparations & Kindred Products2090
  • Food And Kindred Products2000
Product category
Specialty Medical Nutrition
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Formula Products
TypeOne Time License
Description

Cambrooke generates revenue through direct sales of medical nutrition formulas including Glytactin (PKU), Tylactin (TYR), amino acid formulas (HCU, MSUD, IVA), and KetoVie ketogenic products. Products are sold as one-time purchases through e-commerce with case and single-unit pricing options. Healthcare providers and insurance reimbursement (HCPCS codes B4157, B4162) also facilitate product access.

shop.cambrooke.com
2Low Protein Specialty Foods
TypeOne Time License
Description

Direct-to-consumer sales of low protein specialty foods including breads, baked goods, pasta, meat alternatives, snacks, and prepared meals through their online store. Products are sold in single units and cases with prices ranging from approximately $8 to $60 per item.

shop.cambrooke.com
3Ketogenic Foods (KetoVie Café)
TypeOne Time License
Description

Sales of ready-to-use ketogenic foods including Cinnamon Donut Delights, Creamy Cereal, Kwik Mix, Pizza Petites, and Wholesome Bread. Products sold through e-commerce with single and case pricing.

shop.cambrooke.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Pricing details6 tiers
1KetoVie Café Cinnamon Donut Delights - $15.99 single / $79.69 case
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Single unit: 12 x 336g containers at $15.99. Case: $79.69.

shop.cambrooke.com
2KetoVie Café Creamy Cereal - $39.99 single / $332.41 case
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Single unit pricing at $39.99. Case pricing at $332.41.

shop.cambrooke.com
3KetoVie Café Kwik Mix - $42.49 single / $242.15 case
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Single case (10 x 680g) at $42.49. Case pricing at $242.15.

shop.cambrooke.com
4KetoVie Café Pizza Petites - $36.22 single / $227.88 case
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Single case (12 x 576g) at $36.22. Case pricing at $227.88.

shop.cambrooke.com
5KetoVie Café Wholesome Bread - $54.25 single / $175.66 case
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Single case (10 x 50g) at $54.25. Case pricing at $175.66.

shop.cambrooke.com
6Glytactin and Tylactin Medical Formulas - HCPCS B4157 or B4162
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Medical formulas sold in boxes of 30 single-serve units. Reimbursement available through healthcare insurance with HCPCS codes. Examples: Glytactin RTD 30 x 8.3 fl oz cartons, Tylactin RTD 30 x 8.3 fl oz cartons.

shop.cambrooke.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1Glytactin
Description

Glycomacropeptide (GMP) based medical food for the dietary management of Phenylketonuria (PKU). Includes products like RTD, BUILD, COMPLETE, RESTORE, and BetterMilk.

cambrooke.com
+10 more records
Core offering1 text field

Cambrooke Therapeutics develops, manufactures, and sells medical nutrition formulas and specialty foods for patients with inborn errors of metabolism (PKU, Tyrosinemia, MSUD, HCU, IVA), intractable epilepsy, and severe protein allergies. Its core products include GMP-based Glytactin and Tylactin medical formulas, Amino Acid Plus formulas, KetoVie ketogenic formulas and KetoVie Café ready-to-eat ketogenic foods, low-protein specialty foods, ENU nutritional shakes, and pediatric formulas (Essential Care Jr., EquaCare Jr.). Products are sold directly to patients and caregivers via e-commerce and through healthcare professionals, with reimbursement available under HCPCS codes B4157 and B4162.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Glytactin stabilizes Phe levels throughout the day, eliminating the spikes and troughs seen with alternative PKU preparations, leading to increased energy levels and improved concentration
+3 more records
Product and service9 records
1Glytactin (PKU Medical Formulas)
CategoryPKU Medical Formulas
Description

Glycomacropeptide (GMP)-based medical food product line for the dietary management of Phenylketonuria (PKU). Includes RTD, BUILD, COMPLETE, RESTORE Powder, RESTORE Lite Powder, RTD Lite, BetterMilk, SWIRL, and REFRESH formats. Glytactin is the first and only naturally occurring low-phenylalanine whole protein for PKU, stabilized with essential LNAAs to manage blood Phe levels throughout the day.

2Tylactin (Tyrosinemia Medical Formulas)
CategoryTyrosinemia Medical Formulas
Description

Glycomacropeptide (GMP)-based medical food line for the dietary management of Hereditary Tyrosinemia (TYR). Includes RTD, BUILD, COMPLETE, RESTORE Powder, and REFRESH formats. Utilizes the same GMP technology platform adapted for tyrosine and phenylalanine-restricted diets as an effective alternative to traditional amino acid formulas.

3KetoVie (Ketogenic Medical Formulas)
CategoryKetogenic Medical Formulas
Description

Ketogenic formula products for the dietary management of patients with intractable epilepsy. Includes KetoVie 4:1, KetoVie Peptide 4:1, and KetoVie 3:1 ratio formulas for use in medically supervised ketogenic diet therapy.

4KetoVie Café (Ready-to-Eat Ketogenic Foods)
CategoryKetogenic Specialty Foods
Description

Low-carbohydrate ketogenic friendly foods for individuals following ketogenic diets, including Cinnamon Donut Delights, Creamy Cereal, Kwik Mix, Pizza Petites, Raspberry Muffins, and Wholesome Bread. Sold in single units and cases priced from $15.99 to $54.25 single / $79.69 to $332.41 case.

5Amino Acid Plus Formulas (Homactin AA Plus, Vilactin AA Plus, Isovactin AA Plus)
CategoryAmino Acid Metabolism Disorder Formulas
Description

Ready-to-drink nutritionally complete amino acid formulas for Homocystinuria (HCU), Maple Syrup Urine Disease (MSUD), and Isovaleric Acidemia (IVA). Enhanced with a bone-health blend including Vitamin D (620 IU/g PE), Calcium (677 mg), Phosphorus (664 mg), Zinc, Magnesium, Vitamin K1/K2 MK-7, Inulin, essential fats, DHA, and pre-biotic fiber. OU-D Kosher certified.

6Low Protein Specialty Foods
CategoryLow Protein Specialty Foods
Description

Direct-to-consumer low-protein specialty foods including breads, baked goods, pasta, meat alternatives, snacks, ready meals, sauces, soups, baby foods, and prepared meals for patients with diet-managed metabolic disorders. Sold through the Cambrooke shop in single units and cases priced approximately $8 to $60 per item. Categories include baking, breads, breakfast, cheese, chocolates, desserts, fresh filled pasta, meat alternatives, ready meals, rice and pasta, sauces, sides, snacks, soups and seasonings, and spreads.

7ENU Nutritional Shakes
CategoryNutritional Support Shakes
Description

Nutritional shakes for malnutrition support and nutritional supplementation, marketed under the ENU Nutrition brand. Designed for patients needing complete nutritional support, convenient ready-to-drink options for weight management and malnutrition.

8Essential Care Jr. and EquaCare Jr.
CategoryPediatric Medical Nutrition
Description

Medical nutrition formulas for children with protein-related conditions. Includes Essential Care Jr. Ready-To-Drink formula and EquaCare Jr. medical nutrition product, marketed for children managing severe protein allergies and other protein-related medical conditions.

9Cambrooke Canadian Store
CategoryDistribution Channel (Canada)
Description

Separate Canadian e-commerce storefront at store.nexternal.com/cbfi2002 enabling direct-to-consumer sales of Cambrooke medical formulas, low-protein foods, and ketogenic products to Canadian customers.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Groundbreaking collaboration with scientists at the University of Wisconsin, Madison resulted in the development of Glytactin with glycomacropeptide (GMP), an innovative protein source derived from whey. This partnership created the world's first GMP-based product for PKU dietary management.

2New England Connection for PKU and Allied Disorders (NECPAD)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Lynn Paolella, co-founder of Cambrooke, was a founding member of NECPAD alongside dedicated mothers and clinicians. David Paolella remained a steadfast supporter and contributor to the organization's mission and events.

cambrooke.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global medical nutrition division of Danone specializing in metabolic and disease-specific formulas including PKU, MSUD, and other inborn errors of metabolism — Cambrooke's most direct large-scale competitor across medical formulas and low-protein foods.

TypeBroad incumbent
Description

Established medical and infant nutrition brand (Reckitt Benckiser subsidiary) offering metabolic and specialty formulas; competes with Cambrooke in core medical nutrition categories through broader institutional and retail channels.

TypeBroad incumbent
Description

Major global medical nutrition manufacturer offering disease-specific formulas including metabolic products; competes with Cambrooke in medical foods and pediatric/specialty nutrition.

TypeBroad incumbent
Description

Global medical nutrition business within Nestlé covering rare metabolic disorders, ketogenic diets (Vitaflo brand), and pediatric nutrition; significant overlap with Cambrooke across multiple metabolic franchises.

5Vitaflo
TypeDirect peer
Description

Specialist medical nutrition company (within Nestlé Health Science) focused on inherited metabolic disorders, ketogenic diets, and pediatric nutrition — directly comparable niche footprint and product set to Cambrooke.

TypeEmerging player
Description

Developer of pegvaliase-pqpz and other enzyme and gene therapies for PKU; represents a therapeutic alternative rather than a direct nutrition competitor, but its success would displace medical-food demand for Cambrooke's PKU franchise.

TypeDirect peer
Description

Specialty medical nutrition company producing formulas and foods for inborn errors of metabolism including PKU, MSUD, and other amino acid disorders; competes with Cambrooke across the same metabolic condition set.

8Taranis Medical Nutrition
TypeEmerging player
Description

Niche medical nutrition player providing amino acid-based formulas for rare metabolic conditions; smaller-scale but directly competitive in the same orphan-disease specialty nutrition category as Cambrooke.

TypeOthers
Description

Healthcare-focused growth equity investor; led a prior Cambrooke funding round and remains a known capital partner and comparable touchpoint for specialty medical nutrition investing.

TypeDirect peer
Description

Cambrooke's own sub-brand providing nutritional shakes for malnutrition and weight management; listed separately here to flag the internal brand-level peer that competes with third-party medical nutrition shakes in the malnutrition support category.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cambrooke Therapeutics

Specialty Medical Nutritioncambrooke.com

Cambrooke Therapeutics, a wholly-owned Ajinomoto subsidiary, develops and sells GMP-based medical foods (Glytactin, Tylactin, KetoVie) and low-protein specialty foods for patients with rare inborn errors of metabolism including PKU, tyrosinemia, MSUD, HCU, and intractable epilepsy, primarily through direct-to-consumer e-commerce and healthcare provider channels across the US, Canada, UK, Germany, and Australia.

What Cambrooke Therapeutics does

Cambrooke Therapeutics (legally Ajinomoto Cambrooke, Inc.) is a US-based specialty medical nutrition company founded in 2000 by Lynn and David Paolella in Natick, Massachusetts, now headquartered in Ayer, MA. The company develops, manufactures, and commercializes medical foods and nutritional therapies for patients with inborn errors of metabolism — primarily phenylketonuria (PKU), tyrosinemia (TYR), homocystinuria (HCU), maple syrup urine disease (MSUD), isovaleric acidemia (IVA), and intractable epilepsy — as well as low-protein specialty foods for related dietary conditions.

The company's core technological differentiator is its proprietary glycomacropeptide (GMP)-based platform, commercialized under the Glytactin brand for PKU and Tylactin for tyrosinemia. GMP is a naturally occurring low-phenylalanine whole protein derived from whey through a cheese-making process, combined with large neutral amino acids (LNAAs). The company claims this formulation stabilizes phenylalanine levels throughout the day, reduces Phe absorption across the blood-brain barrier, and normalizes ghrelin (hunger hormone) levels. The broader product portfolio includes amino acid formulas (Homactin AA Plus, Vilactin AA Plus, Isovactin AA Plus), the KetoVie ketogenic formula line for intractable epilepsy, KetoVie Café ready-to-eat ketogenic foods, an extensive low-protein specialty food catalog, and ENU Nutrition shakes. In December 2025, the company launched DreamCap, a new user-friendly closure system compatible with the BoLink feeding platform.

The business operates a direct-to-consumer e-commerce model (shop.cambrooke.com and a separate Canadian storefront) supplemented by a healthcare professional channel with Salesforce-powered sample requests, clinical training, and reimbursement support. Medical formulas are reimbursed via HCPCS codes B4157 and B4162. Products are sold on a one-time purchase basis with unit and case pricing tiers (e.g., KetoVie Café Cinnamon Donut Delights at $15.99 single / $79.69 case). Since 2017, Cambrooke has operated as a wholly-owned subsidiary of Japanese food and biotechnology conglomerate Ajinomoto Co., Inc., which has supported international expansion into the UK, Germany, Canada, and Australia.

Cambrooke Therapeutics firmographics

Firmographics
Name
Cambrooke Therapeutics
Legal name
Ajinomoto Cambrooke, Inc.
Website
https://cambrooke.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
51–100 employees
Short description
Cambrooke Therapeutics, a wholly-owned Ajinomoto subsidiary, develops and sells GMP-based medical foods (Glytactin, Tylactin, KetoVie) and low-protein specialty foods for patients with rare inborn errors of metabolism including PKU, tyrosinemia, MSUD, HCU, and intractable epilepsy, primarily through direct-to-consumer e-commerce and healthcare provider channels across the US, Canada, UK, Germany, and Australia.
Ownership category
akta.pro rank

Cambrooke Therapeutics industry classification

Industry
Product category
Specialty Medical Nutrition
NAICS
Food Manufacturing (311), Food (Health) Supplement Retailers (456191)
SIC
Miscellaneous Food Preparations & Kindred Products (2090), Food And Kindred Products (2000)
akta.pro industry
PRIMARYCRADAGAN
Medical Nutrition & Meal Replacement (RTD, Bars, Powders)
SECONDARYAFAKAJAD
Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium)
Agriculture & Food Production/Food Processing & Manufacturing/Specialty & Functional Foods Manufacturing (Organic, Fortified, Medical Foods)
SECONDARYCRADAEAB
Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic)
SECONDARYCRADABAM
Better-for-You / Functional Snacks (Low Sugar, Keto, Probiotic, Fortified)

Keywords

  • Medical nutrition products
  • Therapeutic medical foods
  • Metabolic disorder formulas
  • Low protein specialty foods
  • Ketogenic medical formulas

Where Cambrooke Therapeutics is headquartered

Location

Headquarters

HQ city
Ayer
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cambrooke Therapeutics business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Formula Products: Cambrooke generates revenue through direct sales of medical nutrition formulas including Glytactin (PKU), Tylactin (TYR), amino acid formulas (HCU, MSUD, IVA), and KetoVie ketogenic products. Products are sold as one-time purchases through e-commerce with case and single-unit pricing options. Healthcare providers and insurance reimbursement (HCPCS codes B4157, B4162) also facilitate product access.
  2. Low Protein Specialty Foods: Direct-to-consumer sales of low protein specialty foods including breads, baked goods, pasta, meat alternatives, snacks, and prepared meals through their online store. Products are sold in single units and cases with prices ranging from approximately $8 to $60 per item.
  3. Ketogenic Foods (KetoVie Café): Sales of ready-to-use ketogenic foods including Cinnamon Donut Delights, Creamy Cereal, Kwik Mix, Pizza Petites, and Wholesome Bread. Products sold through e-commerce with single and case pricing.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goKetoVie Café Cinnamon Donut Delights - $15.99 single / $79.69 case
Unit PricingPay-as-you-goKetoVie Café Creamy Cereal - $39.99 single / $332.41 case
Unit PricingPay-as-you-goKetoVie Café Kwik Mix - $42.49 single / $242.15 case
Unit PricingPay-as-you-goKetoVie Café Pizza Petites - $36.22 single / $227.88 case
Unit PricingPay-as-you-goKetoVie Café Wholesome Bread - $54.25 single / $175.66 case
Unit PricingPay-as-you-goGlytactin and Tylactin Medical Formulas - HCPCS B4157 or B4162

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Cambrooke Therapeutics product offering

Product offering

Core offering

Cambrooke Therapeutics develops, manufactures, and sells medical nutrition formulas and specialty foods for patients with inborn errors of metabolism (PKU, Tyrosinemia, MSUD, HCU, IVA), intractable epilepsy, and severe protein allergies. Its core products include GMP-based Glytactin and Tylactin medical formulas, Amino Acid Plus formulas, KetoVie ketogenic formulas and KetoVie Café ready-to-eat ketogenic foods, low-protein specialty foods, ENU nutritional shakes, and pediatric formulas (Essential Care Jr., EquaCare Jr.). Products are sold directly to patients and caregivers via e-commerce and through healthcare professionals, with reimbursement available under HCPCS codes B4157 and B4162.

Differentiator

Problem solved

Functional benefit

Brands

  • Glytactin: Glycomacropeptide (GMP) based medical food for the dietary management of Phenylketonuria (PKU). Includes products like RTD, BUILD, COMPLETE, RESTORE, and BetterMilk.
  • Tylactin
  • KetoVie
  • KetoVie Café
  • ENU Nutrition
  • Essential Care Jr.
  • EquaCare Jr.
  • Homactin AA Plus
  • Vilactin AA Plus
  • Glytactin eLearning Tool
  • CAMBROOKEcare

Products and services

  • Glytactin (PKU Medical Formulas) Glycomacropeptide (GMP)-based medical food product line for the dietary management of Phenylketonuria (PKU). Includes RTD, BUILD, COMPLETE, RESTORE Powder, RESTORE Lite Powder, RTD Lite, BetterMilk, SWIRL, and REFRESH formats. Glytactin is the first and only naturally occurring low-phenylalanine whole protein for PKU, stabilized with essential LNAAs to manage blood Phe levels throughout the day.
  • Tylactin (Tyrosinemia Medical Formulas) Glycomacropeptide (GMP)-based medical food line for the dietary management of Hereditary Tyrosinemia (TYR). Includes RTD, BUILD, COMPLETE, RESTORE Powder, and REFRESH formats. Utilizes the same GMP technology platform adapted for tyrosine and phenylalanine-restricted diets as an effective alternative to traditional amino acid formulas.
  • KetoVie (Ketogenic Medical Formulas) Ketogenic formula products for the dietary management of patients with intractable epilepsy. Includes KetoVie 4:1, KetoVie Peptide 4:1, and KetoVie 3:1 ratio formulas for use in medically supervised ketogenic diet therapy.
  • KetoVie Café (Ready-to-Eat Ketogenic Foods) Low-carbohydrate ketogenic friendly foods for individuals following ketogenic diets, including Cinnamon Donut Delights, Creamy Cereal, Kwik Mix, Pizza Petites, Raspberry Muffins, and Wholesome Bread. Sold in single units and cases priced from $15.99 to $54.25 single / $79.69 to $332.41 case.
  • Amino Acid Plus Formulas (Homactin AA Plus, Vilactin AA Plus, Isovactin AA Plus) Ready-to-drink nutritionally complete amino acid formulas for Homocystinuria (HCU), Maple Syrup Urine Disease (MSUD), and Isovaleric Acidemia (IVA). Enhanced with a bone-health blend including Vitamin D (620 IU/g PE), Calcium (677 mg), Phosphorus (664 mg), Zinc, Magnesium, Vitamin K1/K2 MK-7, Inulin, essential fats, DHA, and pre-biotic fiber. OU-D Kosher certified.
  • Low Protein Specialty Foods Direct-to-consumer low-protein specialty foods including breads, baked goods, pasta, meat alternatives, snacks, ready meals, sauces, soups, baby foods, and prepared meals for patients with diet-managed metabolic disorders. Sold through the Cambrooke shop in single units and cases priced approximately $8 to $60 per item. Categories include baking, breads, breakfast, cheese, chocolates, desserts, fresh filled pasta, meat alternatives, ready meals, rice and pasta, sauces, sides, snacks, soups and seasonings, and spreads.
  • ENU Nutritional Shakes Nutritional shakes for malnutrition support and nutritional supplementation, marketed under the ENU Nutrition brand. Designed for patients needing complete nutritional support, convenient ready-to-drink options for weight management and malnutrition.
  • Essential Care Jr. and EquaCare Jr. Medical nutrition formulas for children with protein-related conditions. Includes Essential Care Jr. Ready-To-Drink formula and EquaCare Jr. medical nutrition product, marketed for children managing severe protein allergies and other protein-related medical conditions.
  • Cambrooke Canadian Store Separate Canadian e-commerce storefront at store.nexternal.com/cbfi2002 enabling direct-to-consumer sales of Cambrooke medical formulas, low-protein foods, and ketogenic products to Canadian customers.

Quantifiable outcome

  • Glytactin stabilizes Phe levels throughout the day, eliminating the spikes and troughs seen with alternative PKU preparations, leading to increased energy levels and improved concentration
  • +3 more outcomes

Companies that use Cambrooke Therapeutics

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Cambrooke Therapeutics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Cambrooke Therapeutics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • University of Wisconsin, MadisoncoreStrategic or Co-development PartnerGroundbreaking collaboration with scientists at the University of Wisconsin, Madison resulted in the development of Glytactin with glycomacropeptide (GMP), an innovative protein source derived from whey. This partnership created the world's first GMP-based product for PKU dietary management.
  • New England Connection for PKU and Allied Disorders (NECPAD)minorStrategic or Co-development PartnerLynn Paolella, co-founder of Cambrooke, was a founding member of NECPAD alongside dedicated mothers and clinicians. David Paolella remained a steadfast supporter and contributor to the organization's mission and events.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Cambrooke Therapeutics competitors and assessment

Company assessment

Direct peers

  • Nutricia: Global medical nutrition division of Danone specializing in metabolic and disease-specific formulas including PKU, MSUD, and other inborn errors of metabolism — Cambrooke's most direct large-scale competitor across medical formulas and low-protein foods.
  • Vitaflo: Specialist medical nutrition company (within Nestlé Health Science) focused on inherited metabolic disorders, ketogenic diets, and pediatric nutrition — directly comparable niche footprint and product set to Cambrooke.
  • Solace Nutrition: Specialty medical nutrition company producing formulas and foods for inborn errors of metabolism including PKU, MSUD, and other amino acid disorders; competes with Cambrooke across the same metabolic condition set.
  • ENU Nutrition: Cambrooke's own sub-brand providing nutritional shakes for malnutrition and weight management; listed separately here to flag the internal brand-level peer that competes with third-party medical nutrition shakes in the malnutrition support category.

Broad incumbents

  • Mead Johnson Nutrition: Established medical and infant nutrition brand (Reckitt Benckiser subsidiary) offering metabolic and specialty formulas; competes with Cambrooke in core medical nutrition categories through broader institutional and retail channels.
  • Abbott Nutrition: Major global medical nutrition manufacturer offering disease-specific formulas including metabolic products; competes with Cambrooke in medical foods and pediatric/specialty nutrition.
  • Nestlé Health Science: Global medical nutrition business within Nestlé covering rare metabolic disorders, ketogenic diets (Vitaflo brand), and pediatric nutrition; significant overlap with Cambrooke across multiple metabolic franchises.

Emerging players

  • BioMarin Pharmaceutical: Developer of pegvaliase-pqpz and other enzyme and gene therapies for PKU; represents a therapeutic alternative rather than a direct nutrition competitor, but its success would displace medical-food demand for Cambrooke's PKU franchise.
  • Taranis Medical Nutrition: Niche medical nutrition player providing amino acid-based formulas for rare metabolic conditions; smaller-scale but directly competitive in the same orphan-disease specialty nutrition category as Cambrooke.

Others

  • Galen Partners: Healthcare-focused growth equity investor; led a prior Cambrooke funding round and remains a known capital partner and comparable touchpoint for specialty medical nutrition investing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Cambrooke Therapeutics social profiles

Digital presence

Cambrooke Therapeutics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cambrooke Therapeutics leadership team

Management profile

Number of profiles

Profiles2 records

Cambrooke Therapeutics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cambrooke Therapeutics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambrooke Therapeutics

What does Cambrooke Therapeutics do?

Cambrooke Therapeutics develops, manufactures, and sells medical nutrition formulas and specialty foods for patients with inborn errors of metabolism (PKU, Tyrosinemia, MSUD, HCU, IVA), intractable epilepsy, and severe protein allergies. Its core products include GMP-based Glytactin and Tylactin medical formulas, Amino Acid Plus formulas, KetoVie ketogenic formulas and KetoVie Café ready-to-eat ketogenic foods, low-protein specialty foods, ENU nutritional shakes, and pediatric formulas (Essential Care Jr., EquaCare Jr.). Products are sold directly to patients and caregivers via e-commerce and through healthcare professionals, with reimbursement available under HCPCS codes B4157 and B4162.

Is Cambrooke Therapeutics a public or private company?

Cambrooke Therapeutics is a private company. It is classified as corporate owned and is currently operating.

When was Cambrooke Therapeutics founded?

Cambrooke Therapeutics was founded in 2000. It employs 51 to 100 people.

Where is Cambrooke Therapeutics based?

Cambrooke Therapeutics is headquartered in Ayer, United States, in the North America region.

How does Cambrooke Therapeutics make money?

Three revenue lines are on record. Medical Formula Products are the primary driver. The others are low Protein Specialty Foods and ketogenic Foods (KetoVie Café).

Who are Cambrooke Therapeutics's main competitors?

Direct peers on record are Nutricia, Vitaflo, Solace Nutrition and ENU Nutrition. Broad incumbents are Mead Johnson Nutrition, Abbott Nutrition and Nestlé Health Science. Emerging players are BioMarin Pharmaceutical and Taranis Medical Nutrition. Galen Partners is listed as an others.

Does Cambrooke Therapeutics have an API?

No public API is recorded for Cambrooke Therapeutics.

What industry is Cambrooke Therapeutics in?

Cambrooke Therapeutics's product category is Specialty Medical Nutrition. Its primary akta.pro industry code is CRADAGAN, Medical Nutrition & Meal Replacement (RTD, Bars, Powders), with a secondary code of AFAKAJAD, Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium). Its NAICS code is 311 and its SIC code is 2090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals